Investor Insights
Asia stocks fall following US political uncertainty, trade tensions
Asia markets were broadly negative on Tuesday morning, following the Dow Jones Industrial Average’s fall overnight amid political uncertainty in the U.S. In Australia, the ASX 200 suffered further losses to trade down by 0.25 percent as its major banks slid. Commonwealth Bank of Australia shares traded lower by 0.75 percent while Westpac Banking Corp fell […]
4 FinTech Myths To Break Right Now
The FinTech industry is growing by leaps and bounds, however, the industry is still surrounded by several misconceptions among the consumers. With its revolutionary and disruptive technology, it is expected to transform the shape of our traditional financial institutions. Nevertheless, there has been a lot of speculation about this, and[…..]
EU Unveils Asia Infrastructure Plan Amid Concerns Over China’s Investment Model
The European Commission proposed on Sept. 19 a foreign policy plan to improve transport, energy, and digital infrastructure links with Asia but denied seeking to counter China‘s ambitions that have raised suspicion in Western countries. The plan, which would be backed by additional funds from the EU’s common budget from 2021,[…..]
UAE gold mine for financial technology: MENA FinTech Association
The Middle East and North Africa region is a gold mine that exists nowhere else in terms of this unique mix of digital penetration, population growth and government support for FinTech, Nameer Khan, Founding Board Member of MENA FinTech told Emirates News Agency (WAM). Abu Dhabi Global Market is on[…..]
Fosun Pharma Sees ‘Huge’ Opportunities in India, Southeast Asia, Africa
Fosun International, led by Shanghai billionaire Guo Guangchang, has long made a name for itself through international partnerships and investments. Fosun Pharma, Fosun’s pharmaceutical arm, is also stepping up its international ties, recently setting up subsidiaries in the U.S. and Europe to expand overseas research and sales. Fosun Pharma in[…..]
Aridis Pharmaceuticals Inc’s Quiet Period Will End on September 24th
Aridis Pharmaceuticals’ (NASDAQ:ARDS) quiet period is set to end on Monday, September 24th. Aridis Pharmaceuticals had issued 2,000,000 shares in its public offering on August 14th. The total size of the offering was $26,000,000 based on an initial share price of $13.00. During the company’s quiet period, insiders and any[…..]